[Combined immunotherapy using interferon-alpha, interleukin-2 and lymphokine-activated killer cells--improvement of quality of life in patients with advanced renal cell carcinoma].

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples